SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biochem Pharma (BCHE) -- Ignore unavailable to you. Want to Upgrade?

To: Steve Bevington who wrote (742)5/2/2000 6:29:00 AM
From: JDN  Respond to of 783
 
Dear Steve: Yes, it has puzzled me, and still does, why BCHE shares languish at these levels. In the past they partnered with GLAXO and shared profits for the sake of wide distribution network etc etc. These new drugs in the pipeline, I understand will be distributed directly by BCHE through a network they have been setting up for many months now. thus all the profits from them will stay in BCHE. Yet, the stock really hasnt done squat!! JDN


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News